Evidence map›Paper›PMID 35136069›Full record

ArticleNature communications2022

Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry.

Bertrand Simon, Hua Jane Lou, Clotilde Huet-Calderwood, Guangda Shi, Titus J Boggon, Benjamin E Turk, David A Calderwood

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Mechanism of ASF1 engagement by CDAN1.Nature communications · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Mechanism of ASF1 Inhibition by CDAN1.bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. iScience · 2024
    Article
  12. Article
  13. Review
  14. Targeting Prostate Cancer, the 'Tousled Way'.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bertrand SimonDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA.
Hua Jane LouDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA.
Clotilde Huet-CalderwoodDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA.
Guangda ShiDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA.
Titus J BoggonDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-2862-1637
Benjamin E TurkDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA. ben.turk@yale.edu.ORCID http://orcid.org/0000-0001-9275-4069
David A CalderwoodDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA. david.calderwood@yale.edu.ORCID http://orcid.org/0000-0002-0791-4142
Yale University · US

Funding

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2015 to 2026
$31.1M
Interaction of substrates and inhibitors with tousled-like kinase 2R03TR002912 · NCATS · YALE UNIVERSITY · PI CALDERWOOD, DAVID A, TURK, BENJAMIN E · 2019 to 2019
$168k
NCATS NIH HHS R03 TR002912NCI NIH HHS P50 CA196530
6 · The paper itself

Abstract

Tousled-like kinases (TLKs) are nuclear serine-threonine kinases essential for genome maintenance and proper cell division in animals and plants. A major function of TLKs is to phosphorylate the histone chaperone proteins ASF1a and ASF1b to facilitate DNA replication-coupled nucleosome assembly, but how TLKs selectively target these critical substrates is unknown. Here, we show that TLK2 selectivity towards ASF1 substrates is achieved in two ways. First, the TLK2 catalytic domain recognizes consensus phosphorylation site motifs in the ASF1 C-terminal tail. Second, a short sequence at the TLK2 N-terminus docks onto the ASF1a globular N-terminal domain in a manner that mimics its histone H3 client. Disrupting either catalytic or non-catalytic interactions through mutagenesis hampers ASF1 phosphorylation by TLK2 and cell growth. Our results suggest that the stringent selectivity of TLKs for ASF1 is enforced by an unusual interaction mode involving mutual recognition of a short sequence motifs by both kinase and substrate.

Indexed as

Molecular MimicryAmino Acid MotifsAmino Acid SequenceCatalytic DomainCell Cycle ProteinsConserved SequenceCrystallography, X-RayHistonesHumansMolecular ChaperonesMolecular Docking SimulationMutagenesisPeptide LibraryPhosphorylationProtein KinasesRecombinant ProteinsASF1A protein, humanASF1B protein, humanCell Cycle ProteinsHistonesMolecular ChaperonesPeptide LibraryProtein Kinasesprotein kinase URecombinant Proteins

Identifiers

PMID35136069
PMCPMC8826447
OpenAlexW4210939592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.